{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7261,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart demonstrates deepening clinical responses over time for NXC-201 therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/28",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 28,
          "from": 23,
          "beatId": "71e54a80-3feb-4065-9889-e8bc30f294b6",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Desire",
          "beatSlug": "aida-desire",
          "evidence": "The clinical highlights and proportion of patients with sCR/CR slides create desire for the solution.",
          "position": 5,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays clinical trial data for NXC-201, specifically focusing on safety profiles and management interventions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/29",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide highlights specific safety metrics (CRS and ICANS) for two dosage groups (100x10^6 and 300x10^6 cells).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/30",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide uses a step-wise process diagram to illustrate dose escalation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/31",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "section_divider",
      "function": "transition",
      "notes": "The slide features a scientific illustration of cellular structures, likely representing the drug's mechanism of action or target environment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/32",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes scientific diagrams of molecular pathways and efficacy data charts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/33",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Slide contains three distinct charts comparing IMX-110 against standard of care and other combinations in mouse models.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/34",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a process diagram illustrating the mechanism of action of IMX-110 in turning cold tumors hot.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/35",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes Kaplan-Meier survival curves and bioluminescence imaging of tumor activity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/36",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 36,
          "from": 29,
          "beatId": "8e23cf32-b5f5-465c-868b-1f5d55ff7e7f",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Interest",
          "beatSlug": "aida-interest",
          "evidence": "The appendix data and peer benchmark slides maintain interest in the solution's details.",
          "position": 6,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/37",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall charts and longitudinal patient response plots. Source note provided at bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/38",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a bubble chart to map clinical trials and a table to summarize drug performance metrics, highlighting low efficacy and high toxicity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/39",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of a conceptual chart and a data table to highlight efficacy and safety in a small sample size (n=4).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/40",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a process flow diagram to show trial progression for two distinct treatment arms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/41",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/42",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow layout to connect platform capabilities to specific product outputs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/43",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a '3 Pillars' framework to explain the platform foundation, followed by a product-specific breakdown.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/44",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes technical diagrams of the drug delivery mechanism and comparative survival data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/45",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume over time and survival curves. References specific dosing schedules and study parameters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/46",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes detailed scientific diagrams of the drug mechanism and clinical trial results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/47",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/48",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is divided into two sections: ImmixBio Clinical Advisory Board (top) and Select Nexcella Scientific Advisory Board (bottom).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/49",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/50",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide is organized into two rows, one for each company's board members, featuring headshots, names, titles, and company logos.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/51",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/52",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/53",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Highlights NXC-201's lower fludarabine dose and Carvykti's longer infusion window.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/54",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of expert testimonials and a comparative clinical trial table to validate the outpatient administration model.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/55",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-55",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 56,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bar chart to contrast the combined annual sales of two sets of oncology drugs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/56",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-56",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 57,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide compares efficacy benchmarks of established competitors (AbbVie, J&J, Takeda) to set a baseline for the IMX-120 opportunity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/57",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-57",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}